Bio Business

» FDA, cancer, tuberculosis and clinical trials

Most Recent

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By Catherine Offord | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.


image: Pharma Cooperates to Achieve Precision Medicine

Pharma Cooperates to Achieve Precision Medicine

By Catherine Offord | February 1, 2017

The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.


image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By Jenny Rood | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.


image: Banking on Blood Tests

Banking on Blood Tests

By Jyoti Madhusoodanan | April 1, 2016

How close are liquid biopsies to replacing current diagnostics?

1 Comment

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By Anna Azvolinsky | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.


image: Picking Up the Pace

Picking Up the Pace

By Kate Yandell | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.


image: Battling the Bulge

Battling the Bulge

By Bob Grant | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.


image: The Sounds of Silence

The Sounds of Silence

By Jenny Rood | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.


image: Clinical Matchmaker

Clinical Matchmaker

By Kate Yandell | June 1, 2015

Enrolling the right patient population could be key to a successful clinical trial.


image: The CAR T-Cell Race

The CAR T-Cell Race

By Vicki Brower | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Renowned Physicist Stephen Hawking Dies
  3. John Sulston, Human Genome Project Leader, Dies
  4. Pupil Response to an Optical Illusion Tied to Autistic Traits